ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Dosage"

  • 2016 American Transplant Congress

    Factors and Outcomes Associated with Daptomycin Non-Susceptible Enterococcal Infections in Solid Organ Transplant Recipients.

    K. Younan,1 R. Lee,1 T. McCarty,1 D. Kunz,2 J. Locke,3 B. Camins,1 P. Pappas,1 J. Baddley,1 A. Nellore.1

    1Medicine, University of Alabama at Birmingham, Birmingham, AL; 2Pharmacy, University of Alabama at Birmingham, Birmingham, AL; 3Surgery, University of Alabama at Birmingham, Birmingham, AL.

    Background: Daptomycin non-susceptible enterococcal (DNSE) infections are associated with poor outcomes. Information regarding factors and outcomes of DNSE in solid organ transplant (SOT) recipients (SOTR)…
  • 2016 American Transplant Congress

    Evaluation of a Risk-Stratified Induction Immunosuppression Protocol Utilizing Low-Dose Antithymocyte Globulin in Renal Transplantation.

    A. Diamond, Z. Khawaja, M. Simpson, S.-C. Kung, M. Akoad, J. Pomposelli, E. Pomfret.

    Solid Organ Transplantation & Hepatobiliary Diseases, Lahey Hospital and Medical Center, Burlington, MA.

    Lower doses of rabbit-derived antithymocyte globulin (rATG) may result in less infection and cost, but may increase the incidence of acute rejection. We compared the…
  • 2016 American Transplant Congress

    Blockade of HLA Antibody-Triggered Classical Complement Activation by High-Affinity Humanized Monoclonal Anti-C1s Antibody TNT009 – Results of a First-in-Human Phase 1 Trial.

    J. Mühbacher,1 B. Jilma,2 M. Wahrmann,3 L. Marinova,3 F. Eskandary,3 J. Gilbert,4 S. Panicker,4 G. Böhmig.3

    1Department of Surgery, Medical University of Vienna, Vienna, Austria; 2Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria; 3Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, Vienna, Austria; 4True North Therapeutics, Inc., South San Francisco, CA.

    Study purpose: Classical complement may play a key role in ABMR. A promising therapeutic approach could be complement inhibition at the level of key component…
  • 2016 American Transplant Congress

    Establishing the Relationship Between Receptor Occupancy, Serum Exposure and Pathway Inhibition by the Blocking, Non-Depleting Anti-CD40 Antibody CFZ533 to Inform Dose Selection in Clinical Transplantation.

    P. Espie, J. Munz, T. Flandre, B. Haraldsson, P. Ulrich, J. Rush.

    Novartis Institutes for Biomedical Research, Basel, Switzerland.

    Background. CD40-CD154 pathway blockade significantly prolongs renal allograft survival in non-human primates (NHPs), and trials of the novel blocking, non-depleting anti-CD40 monoclonal antibody (mAb) CFZ533…
  • 2016 American Transplant Congress

    Advantages of Computerized Dosing Strategy in Tacrolimus Treatment of Renal Transplant Patients.

    S.-Y. Kim,1 S. Cho,1 M.-J. Cho,1 C. Lee,1 A. Han,1 C. Choi,1 S. Ahn,1 S.-I. Min,1 S.-K. Min,1 M. Park,2 I. Jung,3 S. Kim,4 J. Ha.1,2

    1Department of Surgery, Seoul National University Hospital, Seoul, Korea; 2Korea Organ Donation Agency, Seoul, Korea; 3Department of surgery, Seoul Metropolitan Government - Seoul National University Boramae Medical Center, Seoul, Korea; 4Department of Surgery, Myoungji Hospital, Goyang-si, Korea.

    Purpose: Tacrolimus (Tac) is widely used in immunosuppression for kidney transplant (KT) patients. Despite this, it is still difficult for expert physicians to achieve and…
  • 2015 American Transplant Congress

    Thymoglobulin Dosing Efficacy: The Role of ALC on Infection and Rejection

    H. Sarumi, C. Borscheid, G. Sieger, B. Fast, S. Hogan, K. Vassar, T. Pruett.

    University of Minnesota, Minneapolis, MN.

    There are varied Thymoglobulin® (Thymo) induction regimens accepted among transplant programs. Our center uses five doses of Thymo at 1.25mg/kg, yielding a total goal of…
  • 2015 American Transplant Congress

    Ideal Versus Total Body Weight Dosing of Rabbit Anti-Thymocyte Globulin Induction Therapy on Patient Outcomes in High Immunological Risk Kidney Transplant

    M. Vacha, J. Gommer, A. Rege, S. Sanoff, D. Sudan, M. Harris.

    Duke University Hospital, Durham, NC.

    BackgroundThe optimal dose of rabbit anti-thymocyte globulin (rATG) induction therapy in high immunological risk kidney transplantation (KTx) lacks consensus and the effect of dosing weight…
  • 2015 American Transplant Congress

    Assessment of Renal Function in Kidney Transplant Recipients Through Therapeutic Drug Monitoring of Vancomycin

    A. Thamer, N. Elias, C. Varughese, T. Gift, J. Fishman, S. Shao.

    Massachusetts General Hospital, Boston, MA.

    Background: Determining the dose of renally eliminated drugs such as vancomycin in kidney transplant recipients is often challenging due to unclear tools to assess renal…
  • 2015 American Transplant Congress

    Opportunities in Tacrolimus Therapeutic Drug Monitoring

    N. Jandovitz, J. Lee, S. Hammad, J. McKeen, S. Martin, D. Tsapepas.

    Department of Pharmacy, NewYork-Presbyterian Hospital, NY.

    Tacrolimus requires diligent therapeutic drug monitoring (TDM) to maintain appropriate serum concentrations after transplant. To optimize efficacy & minimize toxicity frequent levels are drawn, commonly…
  • 2015 American Transplant Congress

    Impact of Type of Tacrolimus Assay on Therapeutic Drug Monitoring: Need for Standardization

    M. Singh, S. Anwar, D. Brennan, R. Delos Santos.

    Internal Medicine/Nephrology, Washington University School of Medicine, St. Louis, MO.

    Background: Multiple assays are available for measuring tacrolimus (FK) levels and these are not currently standardized. A designated laboratory transitioned their FK assay from Enzyme…
  • « Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences